期刊文献+

泛素-蛋白酶体系统与心血管疾病

Ubiquitin-proteasome system and cardiovascular diseases
下载PDF
导出
摘要 泛素-蛋白酶体系统主要由泛素激活酶(E1)、泛素交联酶(E2)、泛素连接酶(E3)和26S蛋白酶体组成,是降解细胞内蛋白质的主要途径。泛素-蛋白酶体系统参与真核细胞许多生物学功能,如炎症、细胞增生、信号传导、转录调控、细胞凋亡等的调节。近年研究证实泛素-蛋白酶体系统在心血管疾病中具有重要的病理生理学意义,可调节动脉粥样硬化、缺血后再灌注损伤、家族性心肌病、心肌肥厚和心脏衰竭等重要疾病的发生和发展。本文拟就泛素-蛋白酶体系统的结构、功能、调节及在心血管疾病中的作用作一简述。 The ubiquitin-proteasome system (UPS) containing ubiquitin-activating enzyme (El ubuquitin-conjugating enzyme (E2s), ubiquitin-ligase (E3s) and 26S proteasome, is involved in the degradation of most intracel- lular proteins. One major function of UPS is to prevent accumulation of non-functional and potentially toxic proteins. Moreover, it has become clear that the UPS fulfills an important function in most aspects of eukaryotic biology, such as inflammation, cell proliferation, intracellular signaling , transcriptional control, and apoptosis. Recent studies demonstrated that the UPS regulates the initiation and progression of atherosclerosis, ischemia-reperfusion injury, familial cardiomyopathies, about structure, function, regulati hypertrophic and heart failure. This review briefly summarizes current knowledge on of UPS and its pathophysiological role in cardiovascular diseases.
出处 《基础医学与临床》 CSCD 北大核心 2007年第1期16-20,共5页 Basic and Clinical Medicine
基金 国家科学自然科学基金(30570721)
关键词 泛素-蛋白酶体系统 心血管疾病 Ubiquitin-proteasome system cardiovascular diseases
  • 相关文献

参考文献24

  • 1Pickart CM, Eddins MJ. Ubiquitin : structures, functions, mechanisms [J]. Biochim Biophys Acta, 2004, 1695:55-72.
  • 2Herrmann L, Ciechanover A, Lerman LO, et al. The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended [J]. Cardiovasc Res, 2004, 61:11 -21.
  • 3Patterson C. Search and destroy : the role of protein qualitycontrol in maintaining cardiac function[ J]. J Mol Cell Car-diol, 2006, 40:438-441.
  • 4Shenoy SK, McDonald PH, Kohout TA, et al. Begulationof receptor fate by ubiquitination of activated beta 2-adren-ergic receptor and beta-arrestin [ J]. Science, 2001, 294:1307 - 1313.
  • 5Momand J, Wu Hsiao-Huei, Dasgupta G. MDM2-master regulator of the p53 tumor suppressor protein [J]. Gene, 2000, 242:15-29.
  • 6Brown K, Gerstberger S, Carlson L, et al. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation [J]. Science, 1995, 267 : 1485 - 1488.
  • 7Purcell NH, Tang Guilin, Yu Chenfei, et al. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes [J]. Proc Natl Acad Sci USA, 2001, 98:6668 - 6673.
  • 8Hui Hua Li, Kedar V, Zhang Chunlian, et al. Atrogin-1/ muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex [J]. J Clin Invest, 2004, 114:1058 - 1071.
  • 9Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy[J]. Cell, 2004, 117: 399 -412.
  • 10Bachmair A, Finley D, Varshavsky A. In vivo half-life of a protein is a function of its amino-terminal residue [ J ]. Science, 1986, 234:179 - 186.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部